NR4A1 and breast carcinoma: The pooled analyses by hormone receptor status of the five studies showed a similar association as overall for either ER and PR positive breast cancer (pooled RR = 1.034, 95% CI: 0.992; 1.077, I2 = 0.0, p for heterogeneity = 0.52) or ER and PR negative breast cancer (pooled RR = 0.988, 95% CI: 0.925; 1.055, I2 = 6.6, p for heterogeneity = 0.37).